Friday, February 25, 2022 2:34:29 PM
1. Increasing COVISTIX sales as increased production allows for bidding on larger orders.
2. COVISTIX approvals in Canada and US, with sales following rapidly.
3. ABIVERTINIB(cancer) and PD-L1 marketing approvals in China.
4. COVI-MSC results from Brazil. If they are good they might wait for the US results and apply for EUAs in Brazil and US. Or they may just apply for Brazil approval and await the US results.
5. ABIVERTINIB approval for ARDS in intermediate Covid patients in Brazil.
6. COVIDROPS approval in UK and/or Mexico.
7. Mpro oral, broad spectrum anti-viral enters clinic. Will this be partnered?
8. SEMDEXA gains US FDA Breakthrough Designation.
9. RTX advances in phase 2 in cancer pain and arthritic knee pain.
10. SOFUSA advances in phase 2 autoimmune and cancer lymphatic drug delivery.
And the really big news would be a PARTNERSHIP! It is some 9 months since Sorrento announced they were seeking a worldwide ABIVERTINIB centered partnership. Or could there be a broader partnership/buyout agreement following the Genentech/Roche model? Big partnership often take 9-12 months to be completed. They can be complex and there could be several interested Big Pharma.
All of this could happen in Q1 or spill over into Q2. We will just have to wait...but I like our chances!
"The refusal of the real is the number one dogma of our time" Rene Girard
Recent SRNE News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM